OTC · Drug Manufacturers - Specialty & Generic

CLS Holdings USA, Inc. (CLSH) Stock

$0.04 +0.00% OTC: CLSH Healthcare

CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters.

Valuation

MetricValue
Price$0.04
Market Cap$5.94M
P/E Ratio-0.79
P/B Ratio-0.30
P/S Ratio0.30
EPS (TTM)$-0.05
52-Week High$0.07
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE36.74%
ROA-56.63%
ROCE31.67%
Gross Margin42.68%
Operating Margin-10.00%
Net Margin-22.48%
Debt/Equity-0.73
Current Ratio0.23

Annual Financials (USD)

Metric20192020202120222023
Revenue$12.0M$19.0M$23.0M$23.0M$20.0M
Operating Profit$-3.0M$-1.0M$2.0M$-4.0M$-2.0M
Net Profit$-34.0M$-16.0M$-2.0M$-14.0M$-4.0M
EPS$-1.07$-0.50$-0.08$-0.23$-0.05
Op Margin-23.6%-6.0%8.2%-16.3%-10.0%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$15.0M$12.0M$16.0M$10.0M$8.0M
Total Liabilities$21.0M$27.0M$33.0M$24.0M$21.0M
Cash$3.0M$2.0M$3.0M$1.0M$1.0M
Borrowings$19.0M$23.0M$26.0M$14.0M$9.0M

Latest News

ASML Stock Drops 11% as China Starts Producing DUV Tools GuruFocus.com · Jul 28, 2026 Meta Unveils $14 Billion AI Data-Center Venture With BlackRock GuruFocus.com · Jul 28, 2026 HelloNation Article Featuring Plumbing Expert Jessica Gerdeman Explains Water Pressure Problems That Need a Plumber PR Newswire · Jul 28, 2026 HelloNation Article Details Disaster Recovery vs. Data Backup, Featuring IT Expert Nick Kammerdiener PR Newswire · Jul 28, 2026 Global Digital Transformation in Healthcare Market Size/Share Worth USD 270.9 Billion by 2035 at a 14.13% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) GlobeNewswire · Jul 28, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-3.0M$-3.0M$-3.0M$0$1.0M
Investing Cash Flow$-2.0M$1.0M$0$0$0
Financing Cash Flow$0$0$3.0M$0$0
Net Cash Flow$-8.0M$-1.0M$1.0M$-2.0M$0
Free Cash Flow$-5.0M$-3.0M$-4.0M$0$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA35.62
FCF Yield11.12%
Quick Ratio0.09
Interest Coverage-1.05
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRDFAcreage Holdings, Inc. $0.12 +2.52% -0.01 $4.88M 0.00%
ACRHFAcreage Holdings, Inc. $0.00 -0.01 $4.88M 0.00%
BCBCFThe BC Bud Corporation $0.04 -3.31% -1.92 $5.98M 0.00%
CHNCChina Infrastructure Construction Corp. $0.00 0.03 $5.04M 0.00%
FFLWFFire & Flower Holdings Corp. $0.12 -44.37% -0.14 $5.42M 0.00%

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.

CLS Holdings USA, Inc. is headquartered in US.

CLS Holdings USA, Inc. (CLSH) stock trades at $0.04 with a market capitalization of $5.94M. The stock is valued at a price-to-earnings (P/E) ratio of -0.79, price-to-book of -0.30, price-to-sales of 0.30. Over the past 52 weeks the stock has ranged between $0.02 and $0.07, and currently trades 42.9% below its 52-week high.

On profitability, CLS Holdings USA, Inc. generates a return on equity (ROE) of 36.74% — well above the market average, a sign of a high-quality business, return on capital employed of 31.67%, an operating margin of -10.00%, a net profit margin of -22.48%.

Official website: www.clsholdingsinc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides